We investigated the postischemic alterations in dopamine D 1 receptor and Ca 2+/calmodulin independent cyclic adenosine monophosphate (cyclic AMP) selective phosphodiesterase in gerbils and examined the effect of pentobarbital on these alterations. [ 3H]SCH 23390 and [ 3H]rolipram, respectively, were used to label dopamine D 1 receptor and Ca 2+/calmodulin independent cyclic-AMP selective phosphodiesterase. Transient cerebral ischemia was induced for 10 min, and pentobarbital (40 mg/kg) was administered intraperitoneally 30 min prior to ischemia. 5 h after ischemia, [ 3H]rolipram binding decreased significantly in the striatum and hippocampus, whereas no significant change was found in [ 3H]SCH 23390 binding. 7 days after ischemia, however, there was a marked reduction in both [ 3H]SCH 23390 and [ 3H]rolipram binding in the striatum and hippocampus, where histological neuronal damage was found. Pentobarbital significantly ameliorated postischemic decreases in [ 3H]rolipram binding both 5 h and 7 days after recirculation in most areas studied. Furthermore, this drug significantly prevented postischemic reduction in [ 3H]SCH 23390 binding (only) 7 days after ischemia. These results suggest that alteration of cyclic AMP selective phosphodiesterase is more sensitive at an earlier stage after ischemic insult than that of dopamine D 1 receptors. Our results also demonstrate that pentobarbital reduces the alteration in [ 3H]SCH 23390 and [ 3H]rolipram binding after cerebral ischemia.